Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (vol 396, pg 1979, 2020)

Ramasamy, M. N.; Minassian, A. M.; Ewer, K. J.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (vol 396, pg 1979, 2020)

Ramasamy, M. N.; Minassian, A. M.; Ewer, K. J..

Lancet ; 396(10267):1978-1978, 2020.

Article in English | Web of Science | ID: covidwho-1085893

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Language: English Journal: Lancet Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Language: English Journal: Lancet Year: 2020 Document Type: Article